Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparability of prostate trials

S Suciu1, R Sylvester, P Iversen

  • 1EORTC Data Center, Brussels, Belgium.

Cancer
|December 15, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: Results of an international academia-driven compassionate use program.

European journal of cancer (Oxford, England : 1990)·2024
Same author

Introducing extended consultations for patients with severe mental illness in general practice: Results from the SOFIA feasibility study.

BMC primary care·2023
Same author

NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis.

Multiple sclerosis and related disorders·2023
Same author

The SOFIA pilot trial: a cluster-randomized trial of coordinated, co-produced care to reduce mortality and improve quality of life in people with severe mental illness in the general practice setting.

Pilot and feasibility studies·2021
Same author

Clinical efficacy of first and second series of peptide receptor radionuclide therapy in patients with neuroendocrine neoplasm: a cohort study.

Scandinavian journal of gastroenterology·2021
Same author

Investigation of the parameters used in fused deposition modeling of poly(lactic acid) to optimize 3D printing sessions.

International journal of pharmaceutics·2019
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
Same journal

Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

Cancer·2026
Same journal

Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

Cancer·2026
See all related articles

Maximal androgen blockade and classic castration therapy for advanced prostate cancer trials show heterogeneity. Stratifying by castration type and anti-androgen is crucial for valid comparisons in meta-analyses.

Area of Science:

  • Oncology
  • Clinical Trials Methodology
  • Evidence Synthesis

Background:

  • Advanced prostate cancer treatment often involves androgen deprivation therapy.
  • Maximal androgen blockade (MAB) and classic castration therapy (CT) are key treatment modalities.
  • Heterogeneity in clinical trials complicates direct comparisons of MAB versus CT.

Purpose of the Study:

  • To identify randomized clinical trials comparing MAB with CT for advanced prostate cancer.
  • To review sources of heterogeneity in these trials.
  • To propose methods for overcoming heterogeneity in meta-analyses.

Main Methods:

  • Systematic literature search for randomized clinical trials comparing MAB and CT.
  • Identification and categorization of trial heterogeneity (study design, randomization, evaluation, data maturity).

Related Experiment Videos

  • Proposal for a posteriori stratification by castration type and anti-androgen for analysis.

    • Main Results:

    • Significant heterogeneity exists in castration methods (surgical/chemical) and anti-androgens used (flutamide, Anandron, cyproterone acetate).
    • Various factors contribute to heterogeneity, including study design and statistical evaluation.
    • Stratified analysis is essential for comparing like with like.

    Conclusions:

    • Addressing trial heterogeneity through post-hoc stratification is vital for drawing valid conclusions from meta-analyses.
    • Larger trials with longer follow-up provide more robust data for evidence synthesis.
    • Careful methodological considerations are needed for reliable comparisons of MAB and CT.